Income Statement (TTM)
Mangoceuticals, Inc. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Change (%) | 1,126.77 | 128.79 | 97.71 | 47.46 | 15.50 | 2.60 | -12.90 | -18.43 | -17.01 | 0.97 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change (%) | 1,064.39 | 113.64 | 98.87 | 48.30 | 7.72 | 12.15 | -13.76 | -24.52 | -8.25 | -7.03 | |
| % of Revenue | 45.74 | 43.42 | 40.54 | 40.78 | 41.01 | 38.25 | 41.81 | 41.40 | 38.30 | 42.35 | 39.00 |
| Gross Operating Profit | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 |
| Change (%) | 1,179.36 | 140.42 | 96.92 | 46.88 | 20.90 | -3.32 | -12.28 | -14.12 | -22.46 | 6.84 | |
| % of Revenue | 54.26 | 56.58 | 59.46 | 59.22 | 58.99 | 61.75 | 58.19 | 58.60 | 61.70 | 57.65 | 61.00 |
| SG&A | 2 | 4 | 5 | 7 | 9 | 9 | 9 | 9 | 8 | 9 | 12 |
| Change (%) | 119.00 | 24.30 | 28.85 | 22.10 | -0.26 | 9.48 | -8.51 | -7.53 | 14.23 | 33.85 | |
| % of Revenue | 22,333.95 | 3,987.08 | 2,166.14 | 1,411.64 | 1,168.83 | 1,009.32 | 1,077.00 | 1,131.30 | 1,282.44 | 1,765.35 | 2,340.26 |
| R&D | 0 | 0 | -0 | -0 | -0 | ||||||
| Change (%) | 121.63 | -114.08 | 121.63 | ||||||||
| % of Revenue | 119.84 | 116.09 | -8.27 | -15.56 | -33.60 | ||||||
| OpEx | 2 | 4 | 6 | 7 | 9 | 9 | 9 | 9 | 9 | 10 | 13 |
| Change (%) | 100.43 | 45.35 | 22.93 | 23.54 | 4.64 | 1.57 | -5.88 | 0.02 | 12.48 | 30.51 | |
| % of Revenue | 22,379.70 | 3,656.34 | 2,322.77 | 1,444.15 | 1,209.84 | 1,096.13 | 1,085.22 | 1,172.70 | 1,437.90 | 1,948.88 | 2,519.08 |
| Operating Income | -2 | -4 | -6 | -7 | -8 | -8 | -9 | -8 | -8 | -9 | -12 |
| Change (%) | 95.82 | 43.00 | 19.56 | 21.76 | 3.67 | 1.47 | -5.16 | 1.74 | 14.68 | 32.11 | |
| % of Revenue | -22,279.70 | -3,556.34 | -2,222.77 | -1,344.15 | -1,109.84 | -996.13 | -985.22 | -1,072.70 | -1,337.90 | -1,848.88 | -2,419.08 |
| Interest Expense | -0 | -0 | -0 | -0 | -0 | -0 | -0 | ||||
| Change (%) | 13.46 | 102.62 | -97.05 | -0.00 | |||||||
| % of Revenue | -72.41 | -6.70 | -0.36 | -26.44 | -61.50 | -2.22 | -2.68 | ||||
| Net Income | -2 | -5 | -6 | -7 | -9 | -9 | -9 | -9 | -9 | -11 | -14 |
| Change (%) | 127.19 | 43.06 | 12.69 | 25.89 | -2.10 | 1.19 | 2.19 | -6.64 | 28.39 | 27.06 | |
| % of Revenue | -22,352.11 | -4,139.43 | -2,588.26 | -1,475.24 | -1,259.40 | -1,067.52 | -1,052.86 | -1,235.21 | -1,413.63 | -2,187.11 | -2,752.32 |
Source: Capital IQ
